Bio-Techne Corporation (NASDAQ:TECH) Q2 2026 Earnings Call Transcript February 4, 2026 Bio-Techne Corporation beats earnings ...

Q2 2026 Earnings Call February 4, 2026 9:00 AM ESTCompany ParticipantsDavid Clair - VP of Investor Relations & ...

Regenative Labs, in collaboration with Babak Baravarian, DPM, Director of Foot & Ankle Research at University Foot & Ankle ...

The FDA Center for Drug Evaluation and Research has accepted a letter of intent for the first biomarker for idiopathic pulmonary fibrosis into its Biomarker Qualification Program, according to a press ...

The ATS/ERS 2025 statement on interstitial pneumonia classification updates the 2013 statement, with insights on secondary ...

This article was reviewed by Knox Beasley, MD. Key Takeaways: Each hair follicle is a tiny but complex structure. From the ...

Despite major advances in genetic testing for breast cancer risk prediction, death rates remain disproportionately high among ...

CNBC’s Becky Quick joins TODAY to talk about her daughter Kaylie's journey with SynGAP1, a rare genetic disorder that limits the amount of protein intake needed for brain development. Quick opens up ...

Becky Quick and her family have been privately managing her daughter's difficult health woes for the better part of a decade. When the CNBC anchor's daughter Kaylie, now nine years old, was as young ...

The company's 10-Ks for fiscal year 2025 identify certain factors that could cause the company's actual results to differ ...

Knowing which lysosomal proteins are enriched in which brain cell types will help better understand contribution to neurological disorders.

The conversion of large-scale, complex mass spectrometry data into meaningful structural insights through ChemEcho, a machine learning embedding method, published in August by investigators at ...